Weiwei Du
Impact in
- Ophthalmology top 10%
- Retinal Diseases and Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 3
- RNA Research and Splicing 2
- RNA modifications and cancer 2
- Oncology 5
- Co-authors
- Xiang Cheng (1 shared paper)Yan Zhang (1 shared paper)Zhaoliang Chen (1 shared paper)Xiangdong He (3 shared papers)Wei He (3 shared papers)Jinpin Li (2 shared papers)Xuean Mo (2 shared papers)Jingli Liu (2 shared papers)
- Journals
- Oncology Reports (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Genome Medicine (1 paper)Blood (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weiwei Du
16 papers receiving 575 citations
Peers
Comparison fields: 5 of 82
- Ophthalmology 56
- Cancer Research 89
- Immunology 115
- Oncology 144
- Molecular Biology 299
Countries citing papers authored by Weiwei Du
This map shows the geographic impact of Weiwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Du more than expected).
Fields of papers citing papers by Weiwei Du
This network shows the impact of papers produced by Weiwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Du. The network helps show where Weiwei Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 216 | |
| 2 | 2018 | 116 | |
| 3 | 2024 | 34 | |
| 4 | 2017 | 33 | |
| 5 | 2020 | 33 | |
| 6 | 2017 | 30 | |
| 7 | 2016 | 27 | |
| 8 | 2016 | 23 | |
| 9 | 2018 | 18 | |
| 10 | 2017 | 17 | |
| 11 | 2019 | 13 | |
| 12 | A novel sphingosine kinase 1 inhibitor (SKI-5C) induces cell death of Wilms' tumor cells in vitro and in vivo. | 2016 | 11 |
| 13 | 2022 | 5 | |
| 14 | Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers. | 2023 | 2 |
| 15 | 2022 | 1 | |
| 16 | 2016 | 1 |
About Weiwei Du
Weiwei Du is a scholar working on Molecular Biology, Oncology, Neurology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 580 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Acute Myeloid Leukemia Research (2 papers), Ferroptosis and cancer prognosis (2 papers), RNA Research and Splicing (2 papers), Cancer-related molecular mechanisms research (2 papers), Myasthenia Gravis and Thymoma (2 papers), RNA modifications and cancer (2 papers) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Ophthalmology (56 citations), Cancer Research (89 citations), Immunology (115 citations), Oncology (144 citations) and Molecular Biology (299 citations). Weiwei Du has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiang Cheng, Yan Zhang, Zhaoliang Chen, Xiangdong He, Wei He, Jinpin Li, Xuean Mo, Jingli Liu, Jian Pan and Yanfang Tao. Their work appears in journals such as Oncology Reports, Oxidative Medicine and Cellular Longevity, Genome Medicine, Blood and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.